• 715 Citations
  • 14 h-Index
19962019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Anna Zaniboni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 33 Similar Profiles
Seizures Medicine & Life Sciences
Electroencephalography Medicine & Life Sciences
Epilepsy Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Sleep Medicine & Life Sciences
Myoclonus Medicine & Life Sciences
Status Epilepticus Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 715 Citations
  • 14 h-Index
  • 74 Article
  • 2 Review article

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial

Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, Tortora, G., Bonetti, A., Spallanzani, A., Frassineti, G. L., Tassinari, D., Giuliani, F., Cinieri, S., Maiello, E., Verusio, C., Bracarda, S., Catalano, V., Basso, M., Ciuffreda, L., De Vita, F., Parra, H. S., Fornaro, L., Caporale, M., De Braud, F. & Pietrantonio, F., Mar 29 2019, In : BMC Cancer. 19, 1, 283.

Research output: Contribution to journalArticle

Esophagogastric Junction
Paclitaxel
Stomach
Maintenance
Drug Therapy
1 Citation (Scopus)

Gastric cancer: Translating novels concepts into clinical practice

Salati, M., Orsi, G., Smyth, E., Beretta, G., De Vita, F., Di Bartolomeo, M., Fanotto, V., Lonardi, S., Morano, F., Pietrantonio, F., Pinto, C., Rimassa, L., Vasile, E., Vivaldi, C., Zaniboni, A., Ziranu, P. & Cascinu, S., Sep 1 2019, In : Cancer Treatment Reviews. 79, 101889.

Research output: Contribution to journalReview article

Stomach Neoplasms
Continuity of Patient Care
Survival
Combination Drug Therapy
Biomarkers
1 Citation (Scopus)

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., de Braud, F. & Pietrantonio, F., Nov 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Open Access
Disease-Free Survival
Colorectal Neoplasms
Epidermal Growth Factor Receptor
Leucovorin
Survival
3 Citations (Scopus)
Colorectal Neoplasms
Epidermal Growth Factor Receptor
ARQ 197
Cetuximab
Disease-Free Survival
2 Citations (Scopus)
Colonic Neoplasms
Neoplasms
Therapeutics
Survival
Disease-Free Survival